Histoplasmosis in Pregnancy: A Review and Patient Perspective
Abstract
Abstract Histoplasmosis is rarely diagnosed in pregnancy, though when disseminated it may infect the infant as well. Decisions regarding antifungal therapy in pregnant women can be difficult due to known toxicity risks and lack of rigorous study. Here we review the published literature regarding histoplasmosis in pregnancy as well as antifungal therapy in pregnancy and while lactating. We also bring our clinical experience with a disseminated histoplasmosis case affecting both mother and infant, as well as the mother’s perspective in her own words. “Sharing our story is important to me because I hope it can help others. The more information that exists about rare infections and treatments during pregnancy, the better doctors will be able to help families facing similar challenges.”
// Source
Authors: Meredith Kavalier, Jennifer Ross, Kristen Bastug, Nathan C. Bahr, Nicolas Barros, Matthew R. Semler, Shannon Andrews, Alison Galdys
Institutions: University of Minnesota, Indiana University – Purdue University Indianapolis, University of Minnesota Medical Center, Fairview Health Services, 3DT Holdings (United States)